Amyotrophic Lateral Sclerosis: A route to larger CNS markets? - Market Research Reports

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/38007

Amyotrophic Lateral Sclerosis: A route to larger CNS markets?

Description:

Introduction: Amyotrophic lateral sclerosis (ALS) is an orphan neurodegenerative disease which effects less than twenty thousand people across the seven major markets. Nevertheless, ALS is set to provide a platform for drugs for use in more widespread conditions such as Parkinson’s Disease (PD) or Alzheimer’s Disease (AD). Scope: - Epidemiology and prevalence data - Current treatment and unmet market needs - Analysis of trial data, the therapeutic potential of current and future drugs and drug classes - Analysis of key issues in the ALS and orphan disease market supported by key opinion leader interviews Report Highlights: ALS is one of many orphan diseases in the CNS arena. If significant return of investment is to be realized in this market, both existing and future players must address the lack of disease awareness amongst physicians. Currently the only prescription drug approved for ALS is Aventis’ Rilutek (riluzole). Despite the fact that, many physicians doubt its true therapeutic value, Rilutek sales topped $100m in 2002. This demonstrates the scope for commercial opportunities which can be further increased by seeking approval for lucrative indications such as AD or PD. Reasons to Purchase: - Assess the ALS patient potential - Identify the key unmet needs and diagnostic tools, which would highlight novel targets - Review the therapeutic and commercial potential of drugs and compounds in clinical trials based on ALS expert opinion and trial data

Contents:

TABLE OF CONTENTS
EXECUTIVE SUMMARY 5
Introduction 5
Scope and coverage of the Brief 5
Key Findings 6
DISEASE OVERVIEW 9
Symptomatology 9
Etiology 10
Prevalence 11
Diagnosis rate 12
Treatment rates 14
Unmet needs 14
TREATMENT 15
Disease-modifying treatments 15
Symptomatic treatments 17
Non-pharmacological treatment 17
R&D PIPELINE 19
Introduction 19
Marketed drugs in clinical trials for ALS 21
Over-the-Counter Drugs for ALS in clinical trials 25
Therapeutic advances and potential market opportunities 26
Pipeline drugs for ALS 27
STRATEGIC OPPORTUNITIES AVAILABLE TO COMPANIES 31
Introduction 31
Strategic opportunites 31
The orphan drug issues in ALS 32
APPENDIX 37
Contributing experts 37
Bibliography 37
Web sites 40
Disclaimer 42

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/38007

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 02/12/2008 21:03:12

Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com

Order information

Please verify that the product information is correct and select the format you require.


Product Name:
Amyotrophic Lateral Sclerosis: A route to larger CNS markets?
Web Address:
http://www.researchandmarkets.com/reports/38007
Office Code:
OCIFHIOKSRY

Report formats

Please enter the quantity of the report format you require.

	Format	Quantity	Price
	Electronic		€2,033.00

Contact information

Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Page 2 of 2
Printed 02/12/2008 21:03:12

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder Name:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World